$TLOG #2 TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible Senior Notes and Delisting of Common Stock
GlobeNewswire - Wed Nov 2, 4:18PM CDT
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) ("TetraLogic" or "Company"

, a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology...
TLOG : 0.0425 (-15.67%)